TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the signing of a Commercialization and Distribution Agreement (Master Agreement) with QIAGEN Manchester Limited, a wholly owned subsidiary of QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) (QIAGEN). The 10-year agreement provides a foundation for […]
Christian O. Henry Named Chief Executive Officer John F. Milligan, Ph.D. Named Chairman of the Board Ben Gong Named Interim CFO MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced the appointment of Christian O. Henry as President and Chief […]
Innovative AI-driven genomic and proteomic analysis platform for improving cell therapy and immuno-oncology SINGAPORE, 06 August 2020 – Proteona Pte. Ltd. today announced that it has become the first 10x Genomics Certified Service Provider in Singapore. The 10x Genomics Certified Service Provider Program is a global network of single cell analysis companies and laboratories who meet a high […]
SAN DIEGO — Illumina, Inc. (Nasdaq:ILMN). The power to make bigger discoveries is here with the launch of NovaSeqTM 6000 v1.5 Reagent Kit. The new NovaSeq6000 v1.5 Reagent Kits aim to make whole genome sequencing more accessible and affordable for labs of all sizes with the introduction of the $600 genome. By delivering on key customer […]
New solution to remove some of the current unknowns about the virus Boston & Lausanne, Switzerland: SOPHiA GENETICS, leader in Data-Driven Medicine, launches a first-of-its-kind multimodal solution to predict COVID-19 disease evolution, opening new dimensions of insight into the fight against the worldwide pandemic. This advancement goes beyond genomics, analyzing a wider spectrum of data […]
Curated Menu of Off-the-Shelf RNAscope Probes Provide Molecularly-Guided Region of Interest Selection for Use with the New NGS-Enabled Cancer Transcriptome Atlas MINNEAPOLIS and SEATTLE — Bio-Techne (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic markets and NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life […]
Curated Menu of Off-the-Shelf RNAscope Probes Provide Seamless Molecularly-Guided Region of Interest Selection for Use With the New NGS-Enabled Cancer Transcriptome Atlas SEATTLE & MINNEAPOLIS — NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, and Bio-Techne (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for […]
VIENNA — Today Lexogen, the transcriptomics and next-generation sequencing company, announced that Stéphane Barges, PhD, MBA has been appointed as new Chief Executive Officer effective from September 1, 2020. Stéphane Barges of Lexogen Dr. Barges said “Lexogen is already a renowned company thanks to the quality of its very innovative products and of its customer support […]
SAN JOSE, Calif. — Loop Genomics has come one step closer to replacing Sanger sequencing with NGS. Loop’s new product enables massively parallel multiplexing of colonies and cloned DNA’s into a single tube and sequencing them on NGS instruments, reducing the time and cost of sequencing cloned DNA. “The decades old practice of sequencing amplicons from colonies is still prohibitively […]
Manchester, UK: Yourgene Health plc (AIM: YGEN), the international molecular diagnostics group, today announces a proposed placing (the “Placing”) of new ordinary shares of 0.1 pence each (“Ordinary Shares”) in the capital of the Company (the “Placing Shares”) at a price of 17 pence per share (the “Placing Price”) to raise a minimum of £13 million. The […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
